Table 3.
miR-4277 enhanced the sensitivity of MHCC97-H cells to molecular targeted agents, regorafenib, lenvatinib, anlotinib, cabozantinib, or apatinib.
Groups | Regorafenib | Lenvatinib | Anlotinib | Cabozantinib | Apatinib |
---|---|---|---|---|---|
IC50 values of the agents on MHCC97-H cells (μmol/L) | |||||
control miRNA | 0.67 ± 0.49 | 0.55 ± 0.20 | 0.75 ± 0.03 | 0.51 ± 0.19 | 0.96 ± 0.33 |
miR-4277 | 0.22 ± 0.04 | 0.12 ± 0.06 | 0.10 ± 0.01 | 0.10 ± 0.04 | 0.26 ± 0.07 |
miR-4277 + CYP3A4Mut-1 | 0.33 ± 0.32 | 0.41 ± 0.01 | 0.30 ± 0.12 | 0.25 ± 0.06 | 0.52 ± 0.27 |
miR-4277 + CYP3A4Mut-2 | 0.35 ± 0.09 | 0.28 ± 0.11 | 0.45 ± 0.35 | 0.30 ± 0.21 | 0.46 ± 0.30 |
miR-4277 + CYP3A4Mut | 0.71 ± 0.28 | 0.60 ± 0.20 | 0.78 ± 0.55 | 0.56 ± 0.15 | 0.98 ± 0.37 |